EKF Diagnostics Holdings PLC
LSE:EKF
EKF Diagnostics Holdings PLC
Operating Income
EKF Diagnostics Holdings PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Operating Income
£4.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
7%
|
|
Smith & Nephew PLC
LSE:SN
|
Operating Income
$763m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Operating Income
$57m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Operating Income
-$225.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Operating Income
-£24.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Operating Income
-£30.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is EKF Diagnostics Holdings PLC's Operating Income?
Operating Income
4.9m
GBP
Based on the financial report for Dec 31, 2023, EKF Diagnostics Holdings PLC's Operating Income amounts to 4.9m GBP.
What is EKF Diagnostics Holdings PLC's Operating Income growth rate?
Operating Income CAGR 10Y
7%
Over the last year, the Operating Income growth was -43%. The average annual Operating Income growth rates for EKF Diagnostics Holdings PLC have been -32% over the past three years , -3% over the past five years , and 7% over the past ten years .